Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Zubaidah M. Ramdzan, Vasudeva Ginjala, Jordan B. Pinder, Dudley Chung, Caroline M. Donovan, Simran Kaur, Lam Leduy, Graham Dellaire, Shridar Ganesan, Alain Nepveu
Published Jan 28, 2017 · Vol. 8, No. 12 · pp. 19021-19038
Patrizia Mondello, Enrico Derenzini, Zahra Asgari, John Philip, Elliott J. Brea, Venkatraman Seshan, Ronald C. Hendrickson, Elisa de Stanchina, David A. Scheinberg, Anas Younes
Published Jan 28, 2017 · Vol. 8, No. 8 · pp. 14017-14028
Mannan Nouri, Josselin Caradec, Amy Anne Lubik, Na Li, Brett G. Hollier, Mandeep Takhar, Manuel Altimirano-Dimas, Mengqian Chen, Mani Roshan-Moniri, Miriam Butler, Melanie Lehman, Jennifer Bishop, Sarah Truong, Shih-Chieh Huang, Dawn Cochrane, Michael Cox, Colin Collins, Martin Gleave, Nicholas Erho, Mohamed Alshalafa, Elai Davicioni, Colleen Nelson, Sheryl Gregory-Evans, R. Jeffrey Karnes, Robert B. Jenkins, Eric A. Klein, Ralph Buttyan
Published Jan 27, 2017 · Vol. 8, No. 12 · pp. 18949-18967
